| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |